| Trial ID: | L0793 |
| Source ID: | NCT03625284
|
| Associated Drug: |
FucoVital
|
| Title: |
Oral Dietary Fucoxanthin Rich Supplement for Liver Health
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty Liver
|
| Interventions: |
Dietary Supplement: Placebo;Dietary Supplement: FucoVital
|
| Outcome Measures: |
Liver function test: Serum Alanine transaminase (ALT);Liver function test: Aspartate transaminase (AST)Liver function test:Blood gamma-glutamyl transferase (GGT);Liver function test:Blood albumin;Liver function test: Blood bilirubin;Hepatic steatosis;Weight;Waist circumference;Serum lipid profile;Blood glucose status;Inflammation;Kidney function test: serum creatinine;Kidney function test: Glomerular Filtration Rate(GFR);Kidney function test: Blood Urea Nitrogen;Dietary supplement level in the blood
|
| Sponsor/Collaborators: |
Algatechnologies Ltd.
|
| Gender: |
All
|
| Age: |
18 Yearsnan
|
| Phases: |
Not applicable
|
| Enrollment: |
30
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
02/07/2018
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
--
|
| URL: |
https://clinicaltrials.gov/show/NCT03625284
|
